Alliance Pharma plc (AIM:APH)

Alliance Pharma Statistics

Total Valuation

Alliance Pharma has a market cap or net worth of GBP 356.51 million. The enterprise value is 419.85 million.

Market Cap	356.51M
Enterprise Value	419.85M

Important Dates

The last earnings date was Thursday, June 26, 2025.

Earnings Date	Jun 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Alliance Pharma has 551.02 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	551.02M
Shares Outstanding	551.02M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-0.67%
Owned by Insiders (%)	2.35%
Owned by Institutions (%)	95.90%
Float	345.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	13.06
PS Ratio	1.99
PB Ratio	1.72
P/TBV Ratio	n/a
P/FCF Ratio	9.41
P/OCF Ratio	9.21
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.46, with an EV/FCF ratio of 11.09.

EV / Earnings	-39.13
EV / Sales	2.35
EV / EBITDA	11.46
EV / EBIT	14.55
EV / FCF	11.09

Financial Position

The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.46.

Current Ratio	2.84
Quick Ratio	2.14
Debt / Equity	0.46
Debt / EBITDA	2.61
Debt / FCF	2.53
Interest Coverage	3.22

Financial Efficiency

Return on equity (ROE) is -5.04% and return on invested capital (ROIC) is 5.65%.

Return on Equity (ROE)	-5.04%
Return on Assets (ROA)	4.60%
Return on Invested Capital (ROIC)	5.65%
Return on Capital Employed (ROCE)	8.68%
Revenue Per Employee	616,676
Profits Per Employee	-36,997
Employee Count	290
Asset Turnover	0.46
Inventory Turnover	2.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +85.12% in the last 52 weeks. The beta is 0.58, so Alliance Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	+85.12%
50-Day Moving Average	64.03
200-Day Moving Average	51.40
Relative Strength Index (RSI)	71.62
Average Volume (20 Days)	4,303,124

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Alliance Pharma had revenue of GBP 178.84 million and -10.73 million in losses. Loss per share was -0.02.

Revenue	178.84M
Gross Profit	109.29M
Operating Income	28.85M
Pretax Income	-14.46M
Net Income	-10.73M
EBITDA	35.90M
EBIT	28.85M
Loss Per Share	-0.02

Balance Sheet

The company has 32.36 million in cash and 95.70 million in debt, giving a net cash position of -63.34 million or -0.11 per share.

Cash & Cash Equivalents	32.36M
Total Debt	95.70M
Net Cash	-63.34M
Net Cash Per Share	-0.11
Equity (Book Value)	207.64M
Book Value Per Share	0.38
Working Capital	67.64M

Cash Flow

In the last 12 months, operating cash flow was 38.72 million and capital expenditures -841,000, giving a free cash flow of 37.88 million.

Operating Cash Flow	38.72M
Capital Expenditures	-841,000
Free Cash Flow	37.88M
FCF Per Share	0.07

Margins

Gross margin is 61.11%, with operating and profit margins of 16.13% and -6.00%.

Gross Margin	61.11%
Operating Margin	16.13%
Pretax Margin	-8.09%
Profit Margin	-6.00%
EBITDA Margin	20.07%
EBIT Margin	16.13%
FCF Margin	21.18%

Dividends & Yields

Alliance Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.06%
Shareholder Yield	-0.06%
Earnings Yield	-3.01%
FCF Yield	10.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Alliance Pharma has an Altman Z-Score of 1.89. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.89
Piotroski F-Score	n/a